Sigyn Therapeutics to Showcase at the Life Sciences Virtual Investor Forum on September 18th
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 16 2025
0mins
Should l Buy ?
Source: Newsfilter
Company Presentation: Sigyn Therapeutics, Inc. will present at the Life Sciences Virtual Investor Forum on September 18, 2025, with a live Q&A session for investors. An archived webcast will be available for those unable to attend live.
Innovative Therapies: The company has introduced Sigyn Therapy™, a first-in-class device aimed at reducing inflammatory molecules and cholesterol linked to cardiovascular disease, which is the leading cause of death globally. Additionally, Sigyn is developing cancer therapies to enhance immunotherapy and chemotherapy delivery.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
